SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kamron Laboratories - Quaterly Results

26 Sep 2020 Evaluate
The sales for the June 2020 quarter moved down to Rs. 13.62 millions as compared to Rs. 15.85 millions during the year-ago period.The Net Loss for the quarter ended June 2020 is Rs. -2.60 millions as compared to Net Loss of Rs. -6.05 millions of corresponding quarter ended June 2019 Operating profit Margin for the quarter ended June 2020 improved to 0.29% as compared to -3.96% of corresponding quarter ended June 2019


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 13.62 15.85 -14.07 13.62 15.85 -14.07 65.91 55.94 17.82
Other Income 0.00 0.05 0.00 0.00 0.05 0.00 0.23 2.49 -90.76
PBIDT 0.29 -3.96 -107.32 0.29 -3.96 -107.32 -33.13 8.37 -495.82
Interest 0.02 0.00 0.00 0.02 0.00 0.00 0.20 0.73 -72.60
PBDT 0.27 -3.96 -106.82 0.27 -3.96 -106.82 -31.44 7.64 -511.52
Depreciation 2.87 2.09 37.32 2.87 2.09 37.32 4.23 7.34 -42.37
PBT -2.60 -6.05 -57.02 -2.60 -6.05 -57.02 -35.67 0.30 -11990.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 -100.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -2.60 -6.05 -57.02 -2.60 -6.05 -57.02 -35.67 0.27 -13311.11
Equity 58.50 58.50 0.00 58.50 58.50 0.00 58.50 58.50 0.00
PBIDTM(%) 2.13 -24.98 -108.52 2.13 -24.98 -108.52 -50.27 14.96 -435.94

Adline Chem Lab Share Price

11.28 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.30
Dr. Reddys Lab 1219.70
Cipla 1239.30
Zydus Lifesciences 932.80
Lupin 2307.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×